EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Unleashing CAR-T potential in solid tumors: overcoming intrinsic and extrinsic hurdles to improve therapy

Zhiwei Zhang, Dawei Cui, Hao Wang, Liming Wu, Xia Liu

Cancer Immunology, Immunotherapy · 27.01.2026 · 75 (2)

DOI: 10.1007/s00262-025-04278-8 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 27.01.2026. Verfasst von Zhiwei Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, Zhejiang, 311215, PR China. Hauptthemen laut MEDLINE: Neoplasms, Immunotherapy, Adoptive, Receptors, Chimeric Antigen, T-Lymphocytes. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 226 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Zhejiang Provincial Natural Science Foundation of China, National Natural Science Foundation of China, 2023 Hangzhou West Lake Pearl Project Leading Innovative Youth Team Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimeric antigen receptor (CAR) T cell therapy has shown transformative success in hematologic malignancies, yet its application in solid tumors remains limited by a combination of intrinsic and extrinsic barriers. Intrinsically, CAR-T cells face challenges such as CAR instability, T cell exhaustion, insufficient tumor infiltration, and poor persistence. Extrinsically, the tumor microenvironment (TME) acts as a formidable obstacle, with physical barriers, metabolic constraints, and immunosuppressive signals that dampen CAR-T cell function. Recent advancements in CAR transduction, genetic reprogramming, and combination therapies have revealed novel strategies to overcome these hurdles. This review explores cutting-edge innovations aimed at unleashing the full potential of CAR-T therapy in solid tumors, focusing on strategies that enhance CAR-T cell function and persistence while addressing the immunosuppressive TME. By examining both intrinsic and extrinsic factors, we provide a comprehensive framework for future research and clinical application to improve CAR-T therapy for solid tumor treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsImmunotherapy, AdoptiveReceptors, Chimeric AntigenT-LymphocytesHumansTumor MicroenvironmentAnimalsT-Cell Exhaustion

Stichwörter der Autor:innen

CAR transductionCAR-T cellCombination therapySolid tumorTumor microenvironment

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, Zhejiang, 311215, PR China.
  • Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine & Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, Hangzhou, 310003, People's Republic of…
  • Department of Neurosurgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, China.
  • Department of General Surgery, Center for Metabolism Research, The Fourth Affiliated Hospital of Zhejiang University School of Medicine and International School of Medicine, International Institutes of Medicine, Zhejian…
  • ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, Zhejiang, 311215, PR China. L210136@zju.edu.cn.

Förderung

  • Zhejiang Provincial Natural Science Foundation of China
  • National Natural Science Foundation of China
  • 2023 Hangzhou West Lake Pearl Project Leading Innovative Youth Team Project

Zitieren

APA

Zhang, Z., Cui, D., Wang, H., Wu, L., & Liu, X. (2026). Unleashing CAR-T potential in solid tumors: overcoming intrinsic and extrinsic hurdles to improve therapy. Cancer Immunology, Immunotherapy, 75(2). https://doi.org/10.1007/s00262-025-04278-8

Vancouver

Zhang Z, Cui D, Wang H, Wu L, Liu X. Unleashing CAR-T potential in solid tumors: overcoming intrinsic and extrinsic hurdles to improve therapy. Cancer Immunology, Immunotherapy. 2026;75(2). doi:10.1007/s00262-025-04278-8

BibTeX
@article{Zhang2026,
  author = {Zhang, Zhiwei and Cui, Dawei and Wang, Hao and Wu, Liming and Liu, Xia},
  title = {Unleashing CAR-T potential in solid tumors: overcoming intrinsic and extrinsic hurdles to improve therapy},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2026},
  volume = {75},
  number = {2},
  doi = {10.1007/s00262-025-04278-8}
}
Kostenlos starten →